From bench to bedside: Exploring the role of sCD25 in melanoma and lung cancer among sleep apnea patients
Por:
Díaz-García, E, Alfaro, E, Pérez-Moreno, P, Lopez-Fernández, C, García-Sánchez, A, Martínez-García, MA, Mañas, E, Cano-Pumarega, I, Casitas, R, Campos-Rodríguez, F, Sánchez-de-la-Torre, M, Nagore, E, Martorell-Calatayud, A, Blasco, LH, Pastor, E, Abad-Capa, J, Montserrat, JM, Cabriada-Nuño, V, Corral-Peñafiel, J, Arias, E, Mediano, O, Somoza-González, M, Dalmau-Arias, J, Almendros, I, Troncoso-Acevedo, F, Gotera-Rivera, C, Pérez-Warnisher, T, Peces-Barba, G, Seijo, LM, Gozal, D, García-Rio, F and Cubillos-Zapata, C
Publicada:
31 dic 2025
Ahead of Print:
15 dic 2025
Resumen:
Introduction and objectivesThe study examines how hypoxaemia in obstructive sleep apnoea (OSA) relates to cancer. It focuses on CD25, an immune-checkpoint, analyzing its levels in OSA patients with and without cancer to assess whether CD25 could serve as a biomarker for cancer mortality.Materials and methodsWe investigated the plasma levels of soluble CD25 (sCD25) in three independent cohorts: patients with no evidence of cancer, with melanoma, and with lung cancer. We explored the role of hypoxaemia by intermittent hypoxia (IH) and HIF-1 alpha inhibition in vitro models.ResultsOur results suggest that sCD25 increases with hypoxemia severity in OSA, both with or without cancer. OSA patients also exhibit early upregulation of membrane-bound CD25 in T lymphocytes. Our findings corroborate that IH, via HIF-1 alpha, mediates the upregulation of both membrane-bound and sCD25. sCD25 levels correlate with markers of melanoma and lung cancer aggressiveness, and elevated sCD25 levels are associated with higher lung cancer mortality risk.ConclusionOur study indicates that hypoxia mediates the increase of CD25 in OSA patients. In turn, our data revealed sCD25 were related to tumour aggressiveness in OSA patients with melanoma or lung cancer, and suggest sCD25 as a potential novel biomarker to stratify OSA patients with lung cancer by mortality risk.
Filiaciones:
Díaz-García, E:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Paz Inst Hlth Res IdiPAZ, Resp Dis Dept, Resp Dis Grp, Madrid, Spain
Alfaro, E:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Paz Inst Hlth Res IdiPAZ, Resp Dis Dept, Resp Dis Grp, Madrid, Spain
Autonomous Univ Madrid, Fac Med, Madrid, Spain
Pérez-Moreno, P:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Paz Inst Hlth Res IdiPAZ, Resp Dis Dept, Resp Dis Grp, Madrid, Spain
Autonomous Univ Madrid, Fac Med, Madrid, Spain
Lopez-Fernández, C:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Paz Inst Hlth Res IdiPAZ, Resp Dis Dept, Resp Dis Grp, Madrid, Spain
García-Sánchez, A:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Univ Ramon & Cajal, Serv Neumol, Madrid, Spain
Martínez-García, MA:
Hosp Univ & Politecn La Fe, Resp Dept, Valencia, Spain
Mañas, E:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Univ Ramon & Cajal, Serv Neumol, Madrid, Spain
Cano-Pumarega, I:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Univ Ramon & Cajal, Serv Neumol, Madrid, Spain
Casitas, R:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Paz Inst Hlth Res IdiPAZ, Resp Dis Dept, Resp Dis Grp, Madrid, Spain
Autonomous Univ Madrid, Fac Med, Madrid, Spain
Campos-Rodríguez, F:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Univ Valme, Resp Dept, IBIS, Seville, Spain
Sánchez-de-la-Torre, M:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Univ Arnau Vilanova & Santa Maria, Grp Precis Med Chron Dis, IRBLleida, Lleida, Spain
Nagore, E:
Inst Valenciano Oncol, Dermatol Dept, Valencia, Spain
Martorell-Calatayud, A:
Hosp Manises, Dermatol Dept, Valencia, Spain
Blasco, LH:
Hosp Gen Univ Alicante, Resp Dept, ISABIAL, Alicante, Spain
Univ Miguel Hernandez, Dept Med Clin, Elche, Spain
Pastor, E:
Hosp San Juan Alicante, Resp Dept, Alicante, Spain
:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Badalona Germans Trias & Pujol, Ctr Invest Biomed, Resp Dept, Madrid, Spain
Montserrat, JM:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
IDIBAPS, Hosp Clin, Resp Dept, Barcelona, Spain
Cabriada-Nuño, V:
Hosp Univ Cruces, Resp Dept, Bilbao, Spain
Corral-Peñafiel, J:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Univ S Pedro Alcantara, Resp Dept, Caceres, Spain
Arias, E:
Hosp 12 Octubre, Resp Dept, Madrid, Spain
Mediano, O:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Univ Guadalajara, Resp Dept, Guadalajara, Spain
Somoza-González, M:
Hosp Consorcio Terrassa, Pneumol Dept, Barcelona, Spain
Dalmau-Arias, J:
Hosp Santa Creu & Sant Pau, Dermatol Dept, Barcelona, Spain
Almendros, I:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Univ Barcelona, Unitat Biofis & Bioengn, Fac Med & Ciencies Salut, Barcelona, Spain
Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain
Troncoso-Acevedo, F:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
IIS Fdn Jimenez Diaz, Serv Neumol, Madrid, Spain
Gotera-Rivera, C:
IIS Fdn Jimenez Diaz, Serv Neumol, Madrid, Spain
Pérez-Warnisher, T:
Clin Univ Navarra, Pulm Dept, Madrid, Spain
Peces-Barba, G:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
IIS Fdn Jimenez Diaz, Serv Neumol, Madrid, Spain
Seijo, LM:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Clin Univ Navarra, Pulm Dept, Madrid, Spain
Gozal, D:
Marshall Univ, Joan C Edwards Sch Med, Huntington, WV USA
García-Rio, F:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Paz Inst Hlth Res IdiPAZ, Resp Dis Dept, Resp Dis Grp, Madrid, Spain
Autonomous Univ Madrid, Fac Med, Madrid, Spain
Cubillos-Zapata, C:
Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain
Hosp Paz Inst Hlth Res IdiPAZ, Resp Dis Dept, Resp Dis Grp, Madrid, Spain
Green Submitted, gold
|